Dasher Neuroscience Exhibits at WPC 2026 and Hosts Cocktail Social in Phoenix

Dasher Neuroscience proudly participated in the World Parkinson Congress 2026 in Phoenix, joining the global Parkinson’s disease community for a week of scientific exchange, collaboration, and meaningful dialogue.

At our exhibition booth, we were pleased to engage with researchers, clinicians, advocacy groups, patients, families, and industry partners, and to share our latest progress in neurodegenerative disease research and therapeutic development. We sincerely thank everyone who visited our booth and took the time to exchange ideas and insights with our team.

A key highlight of the week was our hosted Cocktail Social, featuring a distinguished speaker program. We extend our sincere thanks to all speakers for sharing their perspectives and experiences:

Prof. Charalampos Tzoulis, Professor of Neurology and Neurogenetics at Haukeland University Hospital and the University of Bergen, presented on “The Norwegian Platform Trial Initiatives in Parkinson’s Disease: SLEIPNIR and HYDRA.”

Clyde Campbell, Founder of the Shake It Up Australia Foundation, shared his personal journey in “My Parkinson’s journey & advancing research in Australia.”

Prof. Jane Tseng, CEO of Dasher Neuroscience, delivered a closing talk on “Pioneering AI-Driven Neuroscience Solutions.”

We are deeply grateful to all speakers, guests, and attendees who joined us during WPC 2026 and contributed to a meaningful week of scientific exchange and collaboration.

Dasher Neuroscience is dedicated to advancing neuroscience innovation and delivering transformative therapies for neurodegenerative diseases.